Meghan Mills
Gerontology · Tupelo, MSNPI 1881005858
Payments from drug & device makers
Across 705 payments — averaging $14.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- Boehringer Ingelheim$773
- AstraZeneca$737
- Amgen$675
- plus $5K from 32 others
What the payments were for
- Food & beverage$10,14398%
- Education$1662%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 106 | $1,389 |
| Novo Nordisk | 62 | $1,010 |
| Lilly USA, LLC | 84 | $1,004 |
| Boehringer Ingelheim | 65 | $773 |
| AstraZeneca | 38 | $737 |
| Amgen | 48 | $675 |
| Pfizer | 49 | $586 |
| Novartis | 38 | $559 |
| Bayer | 39 | $529 |
| Daiichi Sankyo Inc. | 24 | $444 |
| Johnson & Johnson | 27 | $386 |
| Astellas Pharma US Inc | 10 | $291 |
| Ironwood Pharmaceuticals, Inc | 17 | $258 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 14 | $221 |
| Otsuka America Pharmaceutical, Inc. | 10 | $216 |
| GSK | 14 | $212 |
| Lundbeck LLC | 9 | $188 |
| Amarin Pharma, Inc. | 8 | $134 |
| Merck | 6 | $89 |
| Esperion Therapeutics, Inc. | 5 | $76 |
| Averitas Pharma Inc. | 3 | $59 |
| Phathom Pharmaceuticals, Inc. | 3 | $54 |
| Sumitomo Pharma America, Inc. | 3 | $49 |
| Corcept Therapeutics | 2 | $41 |
| Biogen | 2 | $37 |
| E.r. Squibb & Sons, L.L.C. | 2 | $32 |
| Seqirus USA Inc | 2 | $30 |
| Shield Therapeutics Inc | 2 | $29 |
| Bausch Health US, LLC | 2 | $28 |
| Acella Pharmaceuticals, LLC | 2 | $28 |
| Arbor Pharmaceuticals, Inc. | 2 | $28 |
| Boston Scientific | 1 | $20 |
| Philips North America LLC | 1 | $19 |
| Nevro Corp. | 1 | $18 |
| Antares Pharma, Inc. | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $13 |
How this compares
$10,309 in reported general payments places this provider in the 90th percentile of 66 gerontology providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 75 | $77,313 |
| JardianceEmpagliflozin | 89 | $57,727 |
| EliquisApixaban | 23 | $22,244 |
| FarxigaDapagliflozin Propanediol | 32 | $22,024 |
| GemtesaVibegron | 36 | $16,335 |
| EntrestoSacubitril/Valsartan | 21 | $14,880 |
| Tresiba Flextouch U-200Insulin Degludec | 12 | $13,067 |
| TrulicityDulaglutide | 11 | $12,017 |
| Synjardy XrEmpagliflozin/Metformin Hcl | 18 | $9,933 |
| XareltoRivaroxaban | 12 | $7,557 |
| KerendiaFinerenone | 11 | $7,295 |
| TradjentaLinagliptin | 12 | $5,937 |
| MyrbetriqMirabegron | 12 | $5,444 |
| SynthroidLevothyroxine Sodium | 45 | $2,571 |
| Rosuvastatin Calcium | 186 | $1,804 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic | $1,010 | $77,31375 claims |
| Boehringer IngelheimJardiance, Synjardy Xr, Tradjenta | $773 | $73,597119 claims |
| PfizerEliquis | $586 | $22,24423 claims |
| AstraZenecaFarxiga | $737 | $22,02432 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $49 | $16,33536 claims |
| NovartisEntresto | $559 | $14,88021 claims |
| Lilly USA, LLCTrulicity | $1,004 | $12,01711 claims |
| Johnson & JohnsonXarelto | $386 | $7,55712 claims |
| BayerKerendia | $529 | $7,29511 claims |
| Astellas Pharma US IncMyrbetriq | $291 | $5,44412 claims |
| AbbVieSynthroid | $1,389 | $2,57145 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 66 gerontology providers in Mississippi.
Other gerontology in Tupelo
- Nicole TaylorTupelo$2K
- Kathy ThomasTupelo$2K
- Hollie WaldronTupelo$2K
- Lakesha ButlerTupelo$817
- Salley WilliamsTupelo$384
- Kellie ThorntonTupelo$280
- Leigh van DevenderOxford$16K
- Justin ColeLaurel$14K
- Shannon WoodsSouthaven$14K
- Shavonne DoyleOxford$14K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.